Sharon M. Watling
Nessuna posizione attualmente
Profilo
Sharon M.
Watling worked as a Senior Director of Clinical Development at Metabasis Therapeutics, Inc. and as a Vice President of Clinical and Regulatory at Vericel Corp.
She holds a doctorate degree from the University of Michigan.
Precedenti posizioni note di Sharon M. Watling
| Società | Posizione | Fine |
|---|---|---|
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Direttore Tecnico/Scientifico/R&S | - |
| VERICEL CORPORATION | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Sharon M. Watling
| University of Michigan | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Sharon M. Watling
